Ocrevus Zunovo 920 mg / 23,000 UNT in 23 mL Injection
RxNorm 2693465
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2693465 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Ocrevus Zunovo 920 mg / 23,000 UNT in 23 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
23 mL hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 mg/ML Injection [Ocrevus Zunovo]
(Atom ID: 12915482)
SYPrescribable
Synonym (SY):
Ocrevus Zunovo (ocrelizumab-hyaluronidase-ocsq 920 mg / 23,000 UNT) per 23 mL Injection
(Atom ID: 12915484)
PSNPrescribable